Sanchez, Fevelyn .
HRN: 23-87-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2023
CEFUROXIME 1.5GM (VIAL)
11/24/2023
11/25/2023
IV
1.5gm
Q8
Leukocytosis (25.7)
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes